OOIR: Observatory of International Research

Papers

(The TQCC of Circulation-Heart Failure is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Two-Year Follow Up of the LATERAL Clinical Trial	149
Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure	132
Unraveling Comorbidities Contribution to Cardiac Diastolic Dysfunction and Heart Failure	83
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program	64
Unraveling the Role of Myocardial Inflammation in ATTR-CM: A Targetable Mechanism?	61
Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review	60
Letter by Jha Regarding Article, “Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality”	59
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP	49
Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis	46
Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction	42
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group	41
Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes	40
Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System	40
It’s Not You, It’s Me: Uncovering Heart-Kidney Relationship Failures	40
Edge-to-Edge Transcatheter Mitral Valve Repair Versus Optimal Medical Treatment in Nonresponders to Cardiac Resynchronization Therapy: The MITRA-CRT Trial	38
Longitudinal Invasive Hemodynamic Assessment in Patients With Acute Decompensated Heart Failure–Related Cardiogenic Shock: A Single-Center Experience	38
Temporary Mechanical Circulatory Support Coordinator: Conception and Implementation of a Novel Role	37
SUSTAINing the Care of Patients With Advanced Heart Failure by Supporting Family Caregivers	37
Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial	36
Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure	35
Why We Should Care About Who Cares for Patients With Heart Failure With Preserved Ejection Fraction	35
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy	35
Challenges for Patients Dying of Heart Failure and Cancer	35
Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study	34
Finerenone Improves Outcomes in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF	33

Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection Fraction	32
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials	32
High-Intensity Care Versus GDMT Titration: Which Rapidly Improves Health Status in Patients With Heart Failure?	32
GDMT Optimization, But Make It Patient-Centered: Understanding Patient Needs During Heart Failure Medication Discussions	31
Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial	31
Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial	31
Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease	31
Outcomes of Combined Heart and Kidney Transplantation Under the New Heart Allocation Policy: A United Organ Network for Organ Sharing Database Analysis	30
Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry	30
Longitudinal Trends in Donor and Recipient Risk Profile, and Clinical Outcomes, for Donation After Circulatory Death Heart Transplantation	29
Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial	29
Rare Etiology of Cardiogenic Shock in Pregnancy	29
Long-Axis Biplane Echocardiography Sensitively Detects the Progressing Functional Deterioration of Mouse Heart	29
2021: A Look Back	28
Case Implementing 2022 AHA/ACC/HFSA Guidelines: Heart Failure Management in Pregnancy: Early Planning, Close Surveillance, and Multidisciplinary Care	28
Physiologic Insights Into Long COVID Breathlessness	27
Response by Kremer et al to Letter Regarding Article, “Acute Impact of Prone Positioning on the Right Ventricle in COVID-19–Associated Acute Respiratory Distress Syndrome”	27
Peripheral Venous Pressure: An Important but Neglected Contributor to Echocardiographic Estimation of Pulmonary Artery Pressure With Exercise	27
Are Men and Women That Different?	26
Response by Liang and Shimada to Letter Regarding Article “Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy”	26
Proteomic Biomarkers of Sacubitril/Valsartan Treatment Response in Heart Failure With Preserved Ejection Fraction: Molecular Insights Into Sex Differences	26
Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance	26
Physical Activity, Sedentary Time, and Heart Failure Risk in Low-Income Black and White Adults Living in the Southeastern United States	26
Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection	26
Cardiac Rehabilitation Among Hospitalized Patients With Heart Failure: Eligibility, Enrollment, and Participation	25
Letter by Qiu and Du Regarding Article, “Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”	25
Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy	25
Response by Colin-Ramirez et al to Letter Regarding Article, “Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”	24
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression	23
Shifting the Shadow of Death	23
Characteristics of United States Counties in Which Heart Failure Clinical Trials of Pharmacotherapy Were Conducted	23
Acute Pulmonary Edema During Impella RP Support: Too Much of a Good Thing	23
Case of High Output Heart Failure Caused by Renal Clear Cell Carcinoma	22
Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials	21
Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx Trial	21
Obesity Is a Heavy Load in Cardiogenic Shock and Mechanical Circulation	21
Association of Pulmonary Artery Pulsatility Index With Adverse Cardiovascular Events Across a Hospital-Based Sample	21
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial	21
Long-Term Outcomes of Early Coronary Artery Disease Testing After New-Onset Heart Failure	20
Impact of Blood Pressure Targets in Patients With Heart Failure Undergoing Postresuscitation Care: A Subgroup Analysis From a Randomized Controlled Trial	20
Calling for Cooperation and Collaboration in Adult Congenital Heart Disease–Related Heart Failure	19
Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy	19
Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine	19
Tranexamic Acid in the Treatment of Refractory Gastrointestinal Arteriovenous Malformation Bleeding in Left Ventricular Assist Device Patients	19
Pathological Evidence of Native Aortic Valve Injury After Impella Support	19
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy	18
Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial	18
PRKAG2 Syndrome Caused by a Novel Missense Variant Mimicked Sporadic Hypertrophic Cardiomyopathy Until Its Progression to Burned-Out Phase	18
Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry	18
Avoiding Catastrophe	17

Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy	17
Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure	17
Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study	17
Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients With Heart Failure by the Clinical Examination	17
How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical Therapy	17
Serial ^99m Technetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis	17
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial	17
Ramping Up the Pressure on the Right Ventricle	17
Early Reduction in Ambulatory Pulmonary Artery Pressures After Initiation of Sacubitril/Valsartan	16
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity	16
Increased Risk of Congestive Heart Failure Following Carbon Monoxide Poisoning	16
Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?	16
Modulation of Pulsatile Left Ventricular Afterload by Renal Denervation in Heart Failure With Preserved Ejection Fraction	16
Letter by Monda and Limongelli Regarding Article, “Changes in Cardiac Function Following Fulminant Myocarditis”	16
Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure	15
Identifying the Mechanisms of a Peripherally Limited Exercise Phenotype in Patients With Heart Failure With Preserved Ejection Fraction	15
Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women	15
Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial	15
Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction	15
Epicardial Fat Paradox and Differential Effects of GLP-1 Receptor Agonists Across Heart Failure Phenotypes	15
A Peek Into the Future: Will Serial Multimarker Testing Help Bring a New Era of Precision Medicine in Heart Failure Patients?	15
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension	15
Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction	15
Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance	15
Prognostic Value of Elevated Levels of Plasma N-Acetylneuraminic Acid in Patients With Heart Failure	15
Infarct Size Reduction With Cyclosporine A in Circulatory Death Rat Hearts: Reducing Effective Ischemia Time With Therapy During Reperfusion	15
Early Outcomes of Heart Transplantation Using Donation After Circulatory Death Donors in the United States	14
Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction—Profibrotic and Proinflammatory Pathways and Genes	14
Nitric Oxide–Mediated Coronary Endothelial Function Is Impaired in Patients With Heart Failure With Preserved Ejection Fraction	14
Reflections on the Win Ratio With Time-to-Event Outcomes	14
Disparities in Hospital Length of Stay Across Race and Ethnicity Among Patients With Heart Failure	14
Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association	14
Plasma Proteomic Patterns Show Sex Differences in Early Concentric Left Ventricular Remodeling	14
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality	14
Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model	14
Practice Patterns and Patient Outcomes After Widespread Adoption of Remote Heart Failure Care	14
Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction	14
Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure	14
Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies	13
The Great Masquerader: Diagnosing Cardiac Sarcoidosis in the Era of Advanced Cardiac Imaging	13
Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study	13
Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure	13
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy	13
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages	13
Cognitive and Procedural Competencies in the Cardiac Intensive Care Unit	12
Novel Trial Design: CHIEF-HF	12
Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry	12
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial	12
Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study	12
Heart Failure With Preserved Ejection Fraction: From a Vascular Perspective	12
Response by Denfeld et al to Letter Regarding Article, “Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure”	12
Race- and Sex-Specific Population Attributable Fractions of Incident Heart Failure	12
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension	12
Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information	12
Microvascular Dysfunction as a Possible Link Between Heart Failure and Cognitive Dysfunction	12
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure	12
Correction to: Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop	12
Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease	12
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics	12
Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk	12
Targeting Iron Deficiency in Heart Failure: Existing Evidence and Future Expectations	12
Correction to: Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Co	11
Management of Hypertension in Patients With Ventricular Assist Devices: A Scientific Statement From the American Heart Association	11
AHA/ACC/HFSA Guidelines Implementation Case Series: Resynchronization Pacing Preferred in Patients With Reduced Ejection Fraction	11
Rethinking the Nomenclature of Heart Failure Cardiogenic Shock: Do We Need to Start De Novo?	11
Letter by Baldovino et al Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”	11
Temporal Trends of Heart Failure Hospitalizations in Cardiology Versus Noncardiology Wards According to Ejection Fraction: 16-Year Data From the SwedeHF Registry	11
Long-Term Electrocardiographic and Echocardiographic Progression of Arrhythmogenic Right Ventricular Cardiomyopathy and Their Correlation With Ventricular Tachyarrhythmias	11
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort	11
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction	11
Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?	11
Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study	11
Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock	11
MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4	11
Risk-Based Approach for the Prediction and Prevention of Heart Failure	11
You Are Where You Eat: The Local Environment and Risk of Heart Failure	11
Response by Park et al to Letter Regarding Article, “Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to	11
Predicted Heart Mass: A Tale of 2 Ventricles	10
Response by Marquetand and Reil to Letter Regarding Article, “Invasive and Echocardiographic Characteristics of a Patient With Severe Pulmonary Valve Regurgitation Pretending Severe Pulmonary Stenosis	10
Cardiomyopathy and Refractory Tachycardia in a Patient With Hereditary Amyloidosis	10

Social Constructs and the Making of Social Determinants of Health: A Pathway for Equity Interventions to Change Heart Failure Outcomes	10
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure	10
Coronary Allograft Vasculopathy: From Predictably Unpredictable to Unpredictably Predictable	10
Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study	10
Conceptualizing Liberation From Venoarterial Extracorporeal Membrane Oxygenation	10
Is There a Logic in Using Device-Based Algorithms to Prevent Heart Failure Decompensations?	10
Optical Coherence Tomography in Cardiac Allograft Vasculopathy	9
Is It Primetime for Finerenone in Heart Failure?	9
Letter by DeFilippis et al Regarding Article, “Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young”	9
Response by Viray et al to Letter Regarding Article, “Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study”	9
Letter by Haddy Regarding Article, “Invasive and Echocardiographic Characteristics of a Patient With Severe Pulmonary Valve Regurgitation Pretending Severe Pulmonary Stenosis”	9
Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications	9
Hospital at Home as a Treatment Strategy for Worsening Heart Failure	9
Is My Patient Fit for Surgery? Navigating Between the Rock of Heart Failure and the Hard Place of Semiurgent Surgery	9
Ventricular Systolic Discordance Post-Premature Ventricular Complex in Constrictive Pericarditis	9
Identification of Clinical Drivers of Left Atrial Enlargement Through Genomics of Left Atrial Size	9
Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations	9
Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound and Machine Learning: A Proof of Concept	9
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial	9
Practice Patterns After Return of Rare Variants Associated With Cardiomyopathy in the Electronic Medical Records and Genomics Network	9
Unmasking Transthyretin Cardiac Amyloidosis Following Transcatheter Aortic Valve Implantation	9
Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association	9
Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure	9